NCT07573540 Optimizing Smart Technology for Addiction Recovery
| NCT ID | NCT07573540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Alcohol Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 416 participants |
| Start Date | 2025-09-24 |
| Primary Completion | 2029-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 416 participants in total. It began in 2025-09-24 with a primary completion date of 2029-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to develop a machine-learning guided recovery messaging system. The main question it aims to answer is can messages be used to: * help people to improve their health * make changes in people's lives to address alcohol and substance use Participants will: * complete surveys * use a recovery-support digital therapeutic system
Eligibility Criteria
Inclusion Criteria: * meet criteria for alcohol use disorder with at least moderate severity (\>= 4 DSM-5 criteria) * in initial remission with most recent use of alcohol between 1 week and 3 months in the past * able to read English * have a smartphone and cellular plan that supports STAR use (Apple iOS or Android) Exclusion Criteria: * medical or psychiatric co-morbidities that preclude use of a smartphone
Contact & Investigator
John Curtin, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT07573540 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07573540 currently recruiting?
Yes, NCT07573540 is actively recruiting participants. Contact the research team at schneck2@wisc.edu for enrollment information.
Where is the NCT07573540 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT07573540 clinical trial?
NCT07573540 is sponsored by University of Wisconsin, Madison. The principal investigator is John Curtin, PhD at University of Wisconsin, Madison. The trial plans to enroll 416 participants.